Veracyte Inc
Change company Symbol lookup
Select an option...
VCYT Veracyte Inc
HKXCY Hong Kong Exchanges and Clearing Ltd
TOMZ TOMI Environmental Solutions Inc
GDXD MicroSectors? Gold Miners -3X Inverse Leveraged ETNs
CWK Cushman & Wakefield PLC
NAUT Nautilus Biotechnology Inc
ZSANQ Zosano Pharma Corp
CHX ChampionX Corp
UTZ UTZ Brands Inc
POSAF POSaBIT Systems Corp
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

Veracyte, Inc. is a genomic diagnostics company. The Company offers customized biomarker testing and analytical services. It offers a complete range of in vitro diagnostic (IVD) and companion diagnostic development services to biopharmaceutical companies and diagnostic companies. It offers tests across various diseases, which include Afirma Genomic Sequencing Classifier for thyroid cancer; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer; Prosigna Breast Cancer Assay for breast cancer; Genomic Sequencing Classifier and Percepta Nasal Swab Test for lung cancer; Envisia Genomic Classifier test for interstitial lung diseases; Decipher Bladder Genomic Classifier test for bladder cancer and Immunoscore Colon Cancer Test for colon cancer. It also offers Immunogram, a spatial molecular analysis and bioinformatics tool that integrates genomic, transcriptomic and proteomic data to help researchers understand the intricacies of the tumor immune microenvironment.

Closing Price
$25.49
Day's Change
-0.47 (-1.81%)
Bid
--
Ask
--
B/A Size
--
Day's High
27.40
Day's Low
25.06
Volume
(Above Average)
Volume:
1,175,869

10-day average volume:
984,230
1,175,869
  • Prev Close
    25.96
  • Today's Open
    26.12
  • Day's Range
    25.06-27.40
  • Avg Vol (10-day)
    984.2K
  • Last (time)
    4:00p ET 08/11/22
  • Last (size)
    3.0K
  • 52-Wk Range
    14.85 - 54.13
    LowHigh
  • (11/04/21 - 05/12/22)
    71.65%
  • 83.2%
  • Market Cap
    1.8B
  • Shares Outstanding
    71.6M
  • -0.69
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.1
  • 105.24
  • (% of float 07/29/22)
    4.99

Latest News

August 11, 2022
4:05 pm ET
BusinessWire
August 03, 2022
6:05 am ET
MarketWatch
August 02, 2022
4:05 pm ET
BusinessWire
July 20, 2022
4:15 pm ET
BusinessWire
July 14, 2022
4:30 pm ET
BusinessWire
July 13, 2022
4:15 pm ET
BusinessWire
June 27, 2022
8:15 am ET
BusinessWire
June 20, 2022
8:15 am ET
BusinessWire
June 03, 2022
8:30 am ET
BusinessWire
May 31, 2022
4:20 pm ET
BusinessWire
May 26, 2022
5:10 pm ET
BusinessWire
5:05 pm ET
BusinessWire
8:15 am ET
BusinessWire
May 16, 2022
4:17 pm ET
BusinessWire
March 01, 2022
6:27 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.